Holen Sie sich die Stockscreener-App
0.16
10.11%
-0.018
Handel nachbörslich:
.16
Schlusskurs vom Vortag:
$0.178
Offen:
$0.172
24-Stunden-Volumen:
758.70K
Relative Volume:
0.17
Marktkapitalisierung:
$156.72K
Einnahmen:
$1.10M
Nettoeinkommen (Verlust:
$-11.23M
KGV:
-0.079
EPS:
-2.025
Netto-Cashflow:
$-6.61M
1W Leistung:
-0.25%
1M Leistung:
-18.91%
6M Leistung:
-71.93%
1J Leistung:
-91.49%
1-Tages-Spanne:
$0.1542
$0.1762
1-Wochen-Bereich:
$0.1542
$0.1797
52-Wochen-Spanne:
$0.1505
$1.99
Matinas Biopharma Holdings Inc Stock (MTNB) Company Profile
Firmenname
Matinas Biopharma Holdings Inc
Sektor
Branche
Telefon
908-443-1860
Adresse
1545 Route 206 South, Suite 302, Bedminster, NJ
Compare MTNB vs VRTX, REGN, MRNA, ARGX, RVMD
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
MTNB
Matinas Biopharma Holdings Inc
|
0.16 | 156.72K | 1.10M | -11.23M | -6.61M | -2.025 |
VRTX
Vertex Pharmaceuticals Inc
|
526.19 | 133.37B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
788.04 | 81.13B | 14.92B | 4.42B | 3.79B | 41.04 |
MRNA
Moderna Inc
|
198.88 | 79.40B | 2.23B | -3.19B | -1.60B | -8.1462 |
ARGX
Argen X Se Adr
|
959.49 | 60.03B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
204.97 | 43.93B | 742.00K | -1.37B | -1.07B | -7.0731 |
Matinas Biopharma Holdings Inc Stock (MTNB) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2021-05-11 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2020-08-26 | Fortgesetzt | Piper Sandler | Overweight |
| 2020-01-27 | Eingeleitet | Piper Sandler | Overweight |
| 2020-01-24 | Eingeleitet | SunTrust | Buy |
| 2020-01-23 | Eingeleitet | SunTrust | Buy |
| 2020-01-09 | Eingeleitet | Aegis Capital | Buy |
| 2019-06-26 | Eingeleitet | H.C. Wainwright | Buy |
Alle ansehen
Matinas Biopharma Holdings Inc Aktie (MTNB) Neueste Nachrichten
Stock splits calendar for: - Yahoo Finance Singapore
Matinas BioPharma announces one-for-fifteen reverse stock split approval By Investing.com - Investing.com India
Matinas BioPharma announces one-for-fifteen reverse stock split approval - Investing.com
Form 8K Matinas BioPharma Holdings Inc For: 16 September By Investing.com - Investing.com Canada
Matinas BioPharma Announces One-for-Fifteen Reverse Stock Split - TipRanks
Matinas BioPharma to implement 1-for-15 reverse stock split effective Sept. 28, 2026 - TradingView
A first commercial hydrogen deal covers up to 1,000 kilograms a day from GH Power’s facility. - Stock Titan
Price to sales forward of Matinas Biopharma Holdings, Inc. – BOATS:MTNB - TradingView
Matinas BioPharma Share PriceMTNB, RNS News, Articles, Quotes, & Charts (OTCMKTS:MTNB) - Proactive financial news
Matinas Biopharma (MTNB) Holds Steady at $0.18 as Key Support HoldsRVOL Breakout - dars.gov.et
Matinas BioPharma Faces NYSE American Compliance Challenges - TipRanks
Matinas BioPharma Receives New NYSE American Delisting Risk on Equity Shortfall - minichart.com.sg
Matinas BioPharma Receives NYSE American Noncompliance Notice for Continued Listing Standards - Quiver Quantitative
Matinas BioPharma Received Notice of Noncompliance - tradingview.com
Matinas BioPharma Receives Notice of Non-Compliance with NYSE American Continued Listing Standards - GlobeNewswire
symbol__ Stock Quote Price and Forecast - CNN
MTNB Q4 2024 Earnings: Narrower-than-Expected Loss Still Overshadowed by Zero RevenueOne-Time Loss Impact - dars.gov.et
Matinas (MTNB) Results Review: EPS Lands Above Forecast in the Latest Reading; Closing Move: Shares Finish 1.16% Down at the ClosePerformance Review - vinanet.vn
Matinas (MTNB) Session: Finishes 1.16% Down at $0.20 on the Day; Levels: the Near-Term Reference Band Stretches From $0.19 to $0.21 in the Current UpdateWave Equality - vinanet.vn
Matinas (MTNB) Q4 2024 Earnings: EPS Beats Its Estimate at the Close; Market Response: Shares Move 8.93% Higher in the Latest ReadingShare Repurchase Impact - vinanet.vn
12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga
Top Premarket Decliners - marketscreener.com
Matinas (MTNB) Results Review: The Bottom-Line Figure Outpaces Its Comparison for the Current Session; Market Response: The Stock Loses 8.33%Earnings Trend Analysis - vinanet.vn
Matinas Biopharma Holdings Inc. (MTNB) Q4 2024 Earnings: Narrower Loss of -$0.82 Beats Estimates as Clinical Pipeline AdvancesRevenue Warning Signal - vinanet.vn
Matinas BioPharma (MTNB) holder Adam Stern details 9.99% stake and new warrants - Stock Titan
Matinas Biopharma (MTNB) Slips 2.6% to $0.26 as Micro-Cap Biotech Tests SupportInitial Balance - dars.gov.et
US Micro Cap StocksInvest from India - INDmoney
Matinas BioPharma Holdings Inc (MTNB) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Enterprise value to revenue forward of Matinas BioPharma Holdings, Inc. – FWB:6LJ0 - TradingView
12 Health Care Stocks Moving In Friday's After-Market Session - Benzinga
Matinas BioPharma (MTNB) to merge into new GH Power International parent - stocktitan.net
MTNB Q4 2024 Earnings: Narrower-Than-Expected Loss Highlights Cost DisciplineNew Analyst Coverage - dars.gov.et
GH Power and TKMS Continue to Explore Clean Energy Collaboration in Support of Canada’s Future Patrol Submarine Project - Business Wire
Matinas BioPharma (MTNB) and GH Power set 91/9 split in NYSE American deal - Stock Titan
MTNB|Matinas BioPharma Holdings Inc|Price:0.335|Chg%:+0.093 - TradingKey
Matinas BioPharma Holdings Inc - TradingKey
Matinas BioPharma Holdings Inc (MTNB) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
12 Health Care Stocks Moving In Monday's Pre-Market Session - Benzinga
Why Forte Biosciences Shares Are Trading Higher By 39%; Here Are 20 Stocks Moving Premarket - Benzinga
Matinas BioPharma Holdings Inc (MTNB) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Matinas BioPharma Holdings Inc (MTNB) Institutional Confidence - TradingKey
Matinas BioPharma Holdings Inc (MTNB) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Matinas BioPharma Holdings Inc (MTNB) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
TradingKey - TradingKey
Matinas Biopharma Holdings, Inc. Revenue Breakdown – AMEX:MTNB - TradingView
Trending Stocks Today | Matinas BioPharma Surges 44.65% Post-Market - Moomoo
Matinas BioPharma Ends At-The-Market Sales Agreement - TipRanks
Matinas BiopharmaBtig Terminates Sales Agreement With Matinas Biopharma Holdings, Effective Immediately On July 23, 2026SEC Filing - TradingView
Matinas BioPharma $50 Million ATM Program With BTIG Terminated With No Penalties - TradingView
Finanzdaten der Matinas Biopharma Holdings Inc-Aktie (MTNB)
Umsatz
Nettogewinn
Free Cashflow
ENV
3.06%
2.55%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):